Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/does-gender-influence-the-cardiovascular-benefits-observed-with-sodium-ptOFJil50T
- Publisher
- Springer Journals
- Copyright
- Copyright © 2016 by The Author(s)
- Subject
- Medicine & Public Health; Internal Medicine; Cardiology
- ISSN
- 2193-8261
- eISSN
- 2193-6544
- DOI
- 10.1007/s40119-016-0075-1
- Publisher site
- See Article on Publisher Site
Abstract
Cardiol Ther (2017) 6:129–132 DOI 10.1007/s40119-016-0075-1 BRIEF REPORT Does Gender Influence the Cardiovascular Benefits Observed with Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors? A Meta-Regression Analysis . . . Ahmed N. Mahmoud Islam Y. Elgendy Marwan Saad . . . . Akram Y. Elgendy Amr F. Barakat Amgad Mentias Ahmed Abuzaid Anthony A. Bavry Received: October 20, 2016 / Published online: November 28, 2016 The Author(s) 2016. This article is published with open access at Springerlink.com in the patients with type 2 diabetes mellitus ABSTRACT receiving SGLT-2 inhibitors. Introduction: Although a large recent trial had Methods: A search of electronic databases was shown improved cardiovascular outcomes of conducted for all randomized trials comparing diabetic patients on sodium glucose SGLT-2 inhibitors with placebo in patients with co-transporter-2 (SGLT-2) inhibitors, the diabetes mellitus. Primary outcomes were influence of gender differences on such all-cause mortality and cardiovascular outcomes is not known. Thus, we aimed to mortality. Random effects meta-regression was assess the impact of gender on such outcomes conducted using the percentage of women included in the SGLT-2 inhibitor arm of each trial with a P value of \0.1 for statistical Enhanced content To view enhanced content for this significance. article go to http://www.medengine.com/Redeem/1627
Journal
Cardiology and Therapy – Springer Journals
Published: Nov 28, 2016